Antitrust Antitrust

Sham-litigation probe of Sanofi-owned Genzyme closed in Brazil

By Ana Paula Candil
  • 17 Jun 2020 13:32
  • 17 Jun 2020 13:32
A probe of Sanofi-owned Genzyme Corp. and subsidiary Genzyme do Brasil, under which they were accused of launching sham litigation to block competitors in the market for drugs that treat high phosphate levels in the blood, was closed today by the Brazilian competition authority's Tribunal.

Members of the Tribunal of the Administrative Council

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News